Abstract
S-100 CALCIUM BINDING PROTEIN AS PROGNOSTIC FACTOR IN PATIENTS WITH TRAUMATIC BRAIN INJURY

Salma H. Elhassan*, Sawsan A.H. Aldeaf, Alsadig Gassoum,Ghada H. Elhassan, AbdElKarim A. Abdrabo, Mohamed Abdelrahman Arbab

ABSTRACT

Background: Traumatic brain injury (TBI) is the major cause of disability, morbidity, and mortality among individuals younger than 45 years. Age is a strong prognostic factor following TBI compared to other well-accepted prognostic variables such as Glasgow Coma Scale (GCS) and computed tomography category, S-100 B protein is another prognostic factor following TBI and it is the dominant biomarker of TBI in many studies. Materials and methods: This is a cross-sectional hospitalized-based study conducted in the National Center for Neurological Sciences (NCNS), during the period from October 2015 to October 2018. All patients clinically and radiologically diagnosed with TBI at the NCNS during the aforementioned period was enrolled in the study. Patients with non-traumatic brain injury were excluded from this study. Venous blood samples were collected from all participants in sterile plain containers for S-100 protein measurement by Enzyme-Linked Immunosorbent Assay. CT image findings of each patient were recorded and the outcome of patients was determined using the Glasgow Outcome Score (GOS).Results: Eighty-nine patients with TBI were enrolled in the study, 85.4% were males and 14.6% were female. The most affected age group ranged between 19-34 years in 40 patients. The results of this study indicated that 97.7% of the patients showed S-100 protein > 100 ng/L (Reference value=<100 ng/L) P=0.000. Conclusion: The findings of this study showed an association between age and outcome after TBI and an association between S-100 B protein level>150 ng/L and outcome after TBI but not significant to use this marker as a prognostic marker.

Keywords: Traumatic brain injury, S-100 B protein, prognostic factor, outcome, Sudanese patients.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tanima Debnath Sarkar

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2021 Issue has been successfully launched on 1 October 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT